Get startedLog in
    Picture of Santhera Pharmaceuticals Holding AG logo

    SANN — Santhera Pharmaceuticals Holding AG News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Santhera Pharmaceuticals Holding: Receives Positive Recommendation From Nice For Agamree® (Vamorolone) As A Treatment For Duchenne Muscular Dystrophy

    Picture of Santhera Pharmaceuticals Holding AG logoSanthera Pharmaceuticals Holding AG
    10/12/2024 06:02
    Dec 10 (Reuters) - Santhera Pharmaceuticals Holding AG
 SANN.S :
    * RECEIVES POSITIVE RECOMMENDATION FROM NICE FOR AGAMREE®
(VAMOROLONE) AS A TREATMENT FOR DUCHENNE MUSCULAR DYSTROPHY

Source text:  ID:nGNE9gnd45 
Further company coverage:  SANN.S 

 (Reporting by Berlin Newsroom)
 ((berlin.newsroom@thomsonreuters.com;))

    Recent news on Santhera Pharmaceuticals Holding AG

    See all news